The Influence of Cortical Lateralization on Selective Motor Control of the Arm Swing During Independent Walking After Stroke.
Launched by UNIVERSITY HOSPITAL, GHENT · May 29, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the brain controls arm movement while walking, especially in people who have had a stroke. Researchers want to understand the relationship between brain activity and arm swing in individuals who can walk independently after a stroke. They will compare how the brains of stroke survivors and healthy individuals respond during walking and look for ways to help improve arm movement, which is important for better walking after a stroke.
To be eligible for this study, participants who have had a stroke must have experienced their first stroke within the last year, be able to walk for at least 10 minutes, and have some weakness in their arm. Healthy participants must be at least 18 years old and also able to walk for 10 minutes. Throughout the trial, participants can expect to undergo tests that measure their muscle control and brain activity while walking. This research could lead to new treatments that help improve walking and arm movement for those recovering from a stroke.
Gender
ALL
Eligibility criteria
- • Stroke
- Inclusion Criteria:
- • First-ever, ischemic and cerebral stroke
- • Maximum one-year post-stroke
- • Able to walk at least 10 minutes (FAC ≥ 3)
- • Presence of upper limb paresis (NIHSS item 5a/b \> 0)
- Exclusion Criteria:
- • Other neurological disorders
- • Healthy controls
- Inclusion criteria:
- • Older than 18 years
- • Able to walk at least 10 minutes
- Exlusion criteria:
- • Pregnancy
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, East Flanders, Belgium
Ghent, Oost Vlaanderen, Belgium
Patients applied
Trial Officials
Anke Van Bladel, PhD
Principal Investigator
Ghent University and Ghent University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported